期刊文献+

国产和进口奥利司他治疗超重和肥胖症疗效和安全性比较 被引量:6

A comparison of the efficacy and safety of domestic orlistat and imported orlistat in Chinese overweight and obese patients
原文传递
导出
摘要 目的比较国产奥利司他片和进口奥利司他胶囊治疗超重和肥胖症患者的疗效及安全性。方法中国7个中心228例年龄18~65岁、BMI 24-〈40kg/m^2的受试者,在轻度低热卡饮食基础上随机双盲给予国产奥利司他片或进口奥利司他胶囊,治疗24周后评价两种奥利司他的减重疗效以及不良事件。结果经过24周的治疗,国产奥利司他组受试者体重显著降低(5.0±3.7)b,进口奥利司他组下降(4.5±3.5)kg(P=0.3922)。国产奥利司他片减重治疗后受试者收缩压、血TC、LDL—C与基线比较,P值均〈0.0001。收缩压降低(4.4±11.5)mmHg(1mmHg=0.133 kPa),血TC下降(0.54±0.79)mmol/L,LDL-C下降(0.32±0.64)mmol/L,下降幅度与进口奥利司他组相比差异无统计学意义。国产奥利司他组和进口奥利司他组不良事件发生率分别为73.7%和63.7%(组间比较P=0.1167),多为轻度脂肪排泄增多的胃肠道症状,可自行缓解。试验中未发生与药物相关的严重不良事件。结论国产奥利司他片与进口奥利司他胶囊结合轻度低热卡饮食治疗具有相同的减重疗效,并能改善部分肥胖相关疾病,安全性和耐受性好。 Objective To compare the clinical efficacy and safety of domestic orlistat and imported orlistat in Chinese overweight and obese patients. Methods In a randomized, double-blinded and positivecontrolled study, 228 adults (BMI 24 - 〈40 kg/m^2 ) evaluated at seven research centers were randomized to receive domestic orlistat or imported odistat 120 mg 3 times a day with an energy-controlled diet for 24 weeks. Results After 24 weeks, domestic orlistat treated patients got significant weight-loss (5.0 ± 3.7) kg, which was comparable with that of imported orlistat treated patients (4. 5 ± 3.5 ) kg ( P = 0. 3922 ). Compared with the findings before treatment, there was significant decrease of systolic blood pressure (4. 4 ±11.5)mm Hg (1 mm Hg =0,133 kPa) and serum levels of TC (0.54 ±0.79) mmol/L and LDL-C (0. 32±0. 64) mmol/L in the domestic orlistat treated group (compared with levels of baseline, P 〈 0. 0001 ). There was no significant difference between the two groups in the changes of blood pressure and lipid levels. Both groups had similar adverse event profiles, most of which were mild and transient gastrointestinal events. There were no serious adverse events in both groups. Conclusions Domestic orlistat combined with a light low-energy diet promoted significant weight loss, which was comparable with that of imported orlistat after 24 weeks of treatment. There was also improvement in blood pressure and serum levels of TC and LDL-C. Domestic orlistat was as effective and safe as imported orlistat in the treatment of obesity.
出处 《中华内科杂志》 CAS CSCD 北大核心 2009年第10期825-829,共5页 Chinese Journal of Internal Medicine
关键词 肥胖症 奥利司他 Obesity Orlistat
  • 相关文献

参考文献11

  • 1马冠生,李艳平,武阳丰,翟凤英,崔朝辉,胡小琪,栾德春,胡永华,杨晓光.1992至2002年间中国居民超重率和肥胖率的变化[J].中华预防医学杂志,2005,39(5):311-315. 被引量:248
  • 2Goldstein DJ. Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord, 1992,16:397-415.
  • 3Williamson DF. International weight loss:patterns in the general population and its association with morbidity and mortality . Int J Obes Relat Metab Disord, 1997, 21 Suppl 1 : S14-S19.
  • 4Lissner L, Heitmann BL. Dietary fat and obesity: evidence from epidemiology. Eur J Clin Nutr, 1995, 49: 79-90.
  • 5Wing RR, Phelan S. Long-term weight loss maintenance. Am J Clin Nutr, 2005,82:222S -225S.
  • 6Pi-Sunyer FX. A review of long-term studies evaluating the efficacy of weight loss in ameliorating disorders associated with obesity. Clin Ther, 1996,18 : 1006-1035.
  • 7Padwal R, Li SK, Lau DC. Long term pharmacotherapy for obesity and overweight. Cochrane Database Syst Rev, 2003, 4 : CD004094.
  • 8史轶蘩,潘长玉,高妍,樊继援,邹大进,刘志民,刘超,李红,谷卫,李秀钧,林丽香,翁建平.奥利司他在中国超重或肥胖2型糖尿病患者中的疗效分析[J].中华内分泌代谢杂志,2004,20(5):403-407. 被引量:16
  • 9Torgerson JS, Hauptman J, Boldrin MN, et al. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 2004,27 : 155-161.
  • 10Ballinger A, Peikin SR. Orlistat: its current status as an antiobesity drug. Eur J Pharmacol, 2002,440 : 109-117.

二级参考文献10

共引文献261

同被引文献37

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部